CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen

✍ Scribed by Ruiter, Rikje; Bijl, Monique J; van Schaik, Ron HN; Berns, Els MJJ; Hofman, Albert; Coebergh, Jan-Willem W; van Noord, Charlotte; Visser, Loes E; Stricker, Bruno HCh

• Book ID: 121200871
• Publisher: Future Medicine
• Year: 2010
• Tongue: English
• Weight: 588 KB
• Volume: 11
• Category: Article
• ISSN: 1462-2416
• DOI: 10.2217/pgs.10.112